Primary cns lymphoma: Combined treatment with chemotherapy and radiotherapy

Neurology

Volumn 40, Issue 1, 1990, Pages 80-86

  Deangelis, L M ^a   Yahalom, J ^a   Heinemann, M H ^a   Cirrincione, C ^a   Thaler, H T ^a   Krol, G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DEXAMETHASONE; METHOTREXATE;

ARTICLE; BRAIN; CLINICAL ARTICLE; COMPUTER ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; PRIORITY JOURNAL;

ADULT; AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMAN; LYMPHOMA; MALE; METHOTREXATE; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; SUPPORT, NON-U.S. GOV'T;

EID: 0025139869     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.40.1.80     Document Type: Article

References (32)

1. Jellinger K, Radaskiewicz TH, Slowik F. Primary malignant lymphomas of the central nervous system in man. Acta Neuropathol (Berl) 1975;6(suppl):95–102.
2. Zimmerman HM. Malignant lymphomas of the nervous system. Acta Neuropathol (Berl) 1975;6(suppl):69–74.
3. Eby NL, Grufferman S, Flannelly CM, Schold SC, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer 1988;62:2461–2465.
4. Murray K, Kun L, Cox J. Primary malignant lymphoma of the central nervous system. J Neurosurg 1986;65:600–607.
5. Sagerman RH, Collier CH, King GA. Radiation therapy of microgliomas. Radiology 1983;149:567–570.
6. Berry MP, Simpson WJ. Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys 1981;7:55–59.
7. Henry JM, Heffner RR, Dillard SH, Earle KM, Davis RL. Primary malignant lymphomas of the central nervous system. Cancer 1974;34:1293–1302.
8. Littman P, Wang CC. Reticulum cell sarcoma of the brain. Cancer 1975;35:1412–1420.
9. Nelson DF, Martz KL, Newall J, Kerman HD, Thomson LW, Byhardt R. Definitive radiation therapy in the treatment of primary non-Hodgkin’s lymphoma of the central nervous system (CNS): preliminary report of RTOG study 8315. Proceedings of Amer Soc Clin Oncol 1988;7:82.
10. Freeman CR, Shustik C, Brisson ML, Meagher-Villemure K, Dylewski I. Primary malignant lymphoma of the central nervous system. Cancer 1986;58:1106–1111.
11. Abelson HT, Kufe DW, Skarin AT, et al. Treatment of central nervous system tumors with methotrexate. Cancer Treat Rep 1981;65:137–140.
12. Ervin T, Canellos GP. Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate. Cancer 1980;45:1556–1557.
13. Loeffler JS, Ervin TJ, Mauch P, et al. Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 1985;3:490–494.
14. Gabbai AA, Hochberg FH, Linggood RM, Bashir R, Hotleman K. High-dose methotrexate for non-AIDS primary central nervous system lymphoma. J Neurosurg 1989;70:190–194.
15. Pollack IF, Lunsford LD, Flickinger JC, Dameshek HL. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 1989;63:939–947.
16. Kawakami Y, Tabuchi K, Ohnishi R, Asari S, Nishimoto A. Primary central nervous system lymphoma. J Neurosurg 1985;62:522–527.
17. Bleyer WA. New vistas for leucovorin in cancer chemotherapy. Cancer 1989;63:995–1007.
18. Kaplan EL, Meier P. Non-parametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457–481.
19. Cox DR. Regression models and life-tables. J Roy Stat Soc 1972;34:187–220.
20. The Non-Hodekin’s Lymphoma Pathologic Classification Project: The National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982;49:2112–2139.
21. Schaumburg HH, Plank CR, Adams RD. The reticulum cell sarcoma-microglioma group of brain tumours. Brain 1972;95:199–212.
22. Neuwelt EA, Frenkel EP, Gumerlock MK, Braziel R, Dana B, Hill SA. Developments in the diagnosis and treatment of primary CNS lymphoma. Cancer 1986;58:1609–1620.
23. Stewart J, Russell N, Dennery J, Richard M, Atack E, Eapen L. Cyclophosphamide, adriamycin, vincristine and dexamethasone in the treatment of bulky central nervous system lymphomas. J Neuroonc 1984;2:289.
24. Rosen G, Ghavimi F, Nirenberg A, Mosende C, Mehta BM. High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children. Cancer Treat Rep 1977;61:681–690.
25. Skarin AT, Zuckerman KS, Pitman SW, et al. High-dose methotrexate with folinic acid in the treatment of non-Hodgkin lymphoma including CNS involvement. Blood 1977;50:1039–1047.
26. Shapiro WR, Young DF, Mehta BM. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975;293:161–166
27. Bleyer WA, Griffin TW. White matter necrosis, mineralizing microangiopathy, and intellectual abilities in survivors of childhood leukemia: associations with central nervous system irradiation and methotrexate therapy. In: Gilbert HA, Kagan AR, eds. Radiation damage to the nervous system. New York Raven Press, 1980:155–174.
28. Rawlinson DG, Billingham ME, Berry PF, Kempson RL. Cytology of the cerebrospinal fluid in patients with Hodgkin’s disease or malignant lymphoma. Acta Neuropathol (Berl) 1975;6(suppl):187–191.
29. Qualman SJ, Mendelsohn G, Mann RB, Green WR. Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature. Cancer 1983;52:878–886.
30. Baumann MA, Ritch PS, Hande KR, Williams GA, Topping TM, Anderson T. Treatment of intraocular lymphoma with high-dose Ara-C. Cancer 1986;57:1273–1275.
31. Mendenhall NP, Thar TL, Agee F, Harty-Golder B, Ballinger WE, Million RR. Primary lymphoma of the central nervous system. Cancer 1983;52:1992–2000.
32. Klimo P. Chemotherapy for aggressive non-Hodgkin’s lymphomas. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer principles and practice of oncology, 2nd ed. Updates, vol 2. Philadelphia: JB Lippincott, 1988.